PRICE T ROWE ASSOCIATES INC /MD/ - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$237
-10.9%
30,379
+10.8%
0.00%
Q2 2023$266
-6.7%
27,411
+5.7%
0.00%
Q1 2023$285
+187.9%
25,927
+12.6%
0.00%
Q4 2022$99
-99.9%
23,021
+7.3%
0.00%
Q3 2022$162,000
+25.6%
21,458
+67.7%
0.00%
Q2 2022$129,000
-97.7%
12,799
-98.3%
0.00%
-100.0%
Q1 2017$5,515,000751,3000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders